MedPath
Found 3 clinical trials|View Analysis
Sort by:

Transarterial Chemoembolization for the Treatment of Lung Cancer and Lung Metastases

Phase 2
Recruiting
Conditions
Lung Non-Small Cell Carcinoma
Mediastinal Neoplasm
Pleural Neoplasm
Lung Metastases From Any Primary
Endobronchial Metastases
Colon Cancer
Sarcoma
Interventions
Procedure: Computed Tomography
Drug: Ethiodized Oil
Drug: Mitomycin
Procedure: Transarterial Chemoembolization
Device: Tris-acryl Gelatin Microspheres
First Posted Date
2023-01-05
Last Posted Date
2024-11-28
Lead Sponsor
City of Hope Medical Center
Target Recruit Count
30
Registration Number
NCT05672108
Locations
🇺🇸

City of Hope Medical Center, Duarte, California, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Phase 4
Completed
Conditions
Endobronchial Metastases
Bronchoesophageal Fistula
General Anesthetic Drug Adverse Reaction
Interventions
First Posted Date
2022-07-21
Last Posted Date
2022-10-26
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
34
Registration Number
NCT05468671
Locations
🇨🇳

Zhejiang Cancer Hospital, Hanzhou, China

Chemoembolization for Lung Tumors

Phase 1
Completed
Conditions
Lung Metastases
Pleural Metastases
Mediastinal Metastases
Endobronchial Metastases
Interventions
Procedure: Chemoembolization
Drug: Mitomycin C
Drug: Lipiodol
Drug: Embospheres
First Posted Date
2019-12-16
Last Posted Date
2022-04-22
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
10
Registration Number
NCT04200417
Locations
🇺🇸

Memoral Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States

🇺🇸

Memoral Sloan Kettering Westchester (Consent only), Harrison, New York, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath